Get started
Author

Valentina Lombardo

Observed names: V. Lombardo, Valentina N Lombardo, Valentina Nunziella Lombardo
ORCID: 0000-0002-0446-6436
Observed ORCID: 0000-0002-0446-6436
OpenAlex ID: A5082697375
A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer (Review)
2021 · Luca Falzone, Giuseppa Scandurra, et al. · International Journal of Oncology · 117
PDF
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors
2024 · Brigida Anna Maiorano, Massimo Di Maio, et al. · JAMA Network Open · 54
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO Network
2022 · Giuseppe Luigi Banna, Umberto Basso, et al. · Current Oncology · 16
PDF
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network
2022 · Pasquale Rescigno, Marco Maruzzo, et al. · The Oncologist · 16
PDF
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group
2022 · Michele Bartoletti, Alice Bergamini, et al. · International Journal of Gynecological Cancer · 13
Pembrolizumab as a single agent for patients with MSI-H advanced endometrial carcinoma
2022 · Margherita Turinetto, Valentina Lombardo, et al. · Expert Review of Anticancer Therapy · 10
Homologous Recombination Deficiency (HRD) Scoring, by Means of Two Different Shallow Whole-Genome Sequencing Pipelines (sWGS), in Ovarian Cancer Patients: A Comparison with Myriad MyChoice Assay
2023 · Giovanni L. Scaglione, Sandro Pignata, et al. · International Journal of Molecular Sciences · 8
PDF
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful?
2024 · Giuseppa Scandurra, Valentina Lombardo, et al. · Cancers · 7
PDF
Management of ocular toxicity in patients with gynecologic cancer receiving novel antibody–drug conjugates: a narrative review
2025 · Giuseppa Scandurra, Filippo Marano, et al. · Clinical & Translational Oncology · 2
PARPi and myeloid neoplasms; the Italian MITO-MaNGO experience based on a multicentric survey
2025 · M. Turinetto, C. Marchetti, et al. · ESMO Open · 1
PDF
Real-World Analysis of HRD Assay Variability in High-Grade Serous Ovarian Cancer: Impacts of BRCA1/2 Mutation Subtypes on HRD Assessment
2025 · Giovanni Luca Scaglione, Valentina Lombardo, et al. · Biomolecules · 1
PDF
Personalizing adjuvant radiotherapy after complete response in locally advanced triple-negative breast cancer: exploring the potential role of BRCA status
2026 · Giuseppa Scandurra, Vittorio Gebbia, et al. · Clinical Breast Cancer
PDF
Clinical challenges in the adaptation of AI predictive models in radiation oncology for gynecological cancer: a systematic review by the radiation oncology-AI MITO group
2026 · Donato Pezzulla, Amelia Barcellini, et al. · International Journal of Gynecological Cancer
A multidisciplinary approach and patient and caregiver education lead to improved prevention and rapid resolution of ocular adverse events in ovarian cancer patients treated with mirvetuximab soravtansine.
2026 · Giuseppa Scandurra, Valentina Lombardo, et al. · International Journal of Gynecological Cancer
Trabectedin maintenance therapy after liposomal doxorubicin plus trabectedin combination in patients with relapsed ovarian cancer: the randomized, phase II TRAMANT study
2025 · Giuseppa Scandurra, Giuseppe Scibilia, et al. · International Journal of Gynecological Cancer
Correction: Identification of the novel BRCA1 c.2463_2464delTA mutation in two high grade serous ovarian cancer sisters and potential dosage effects implications: a case report
2025 · Valentina Lombardo, Giuseppa Scandurra, et al. · Molecular Biology Reports
PDF
Gynecological Cancer Patient Perspectives On The Impact Of Illness And On Clinical Research Awareness: A MITO Group Nationwide Italian Survey
2025 · Giuseppa Scandurra, Sonia Tiziana La Spina, et al. · International Journal of Gynecological Cancer
PDF
Identification of the novel BRCA1 c.2463_2464delTA mutation in two high grade serous ovarian cancer sisters and potential dosage effects implications: a case report
2025 · Valentina Lombardo, Giuseppa Scandurra, et al. · Molecular Biology Reports
Synergistic Immune-Mediated Anti-tumour Effect of Dostarlimab and Radiotherapy in the Management of MSI-H/dMMR Endometrial Cancer: A Case Report
2023 · Giuseppa Scandurra, Valentina Lombardo, et al. · EMJ Oncology
PDF
Works count: 19
Citation count: 245
H-index: 7
I10-index: 6
Year
Topic
Type